EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets

Roland Klingenberg iD, Andreas Leiherer, Dobromir Dobrev iD, Juan C Kaski, Bodo Levkau, Winfried März iD, Samuel Sossalla, Arnold von Eckardstein iD, Heinz Drexel

Cardiovascular Research · 14.08.2025 · 121 (9) · 1345-1358

DOI: 10.1093/cvr/cvaf093 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Research, online erschienen am 03.06.2025. Verfasst von Roland Klingenberg und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Kerckhoff-Klinik, Campus of the University of Giessen, Benekestr. 2-8, D-61231 Bad Nauheim, Germany. Hauptthemen laut MEDLINE: Ceramides, Cardiovascular Diseases, Cardiovascular Agents, Cardiovascular System. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, German Centre for Cardiovascular Research, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ceramides are bioactive lipid mediators involved in apoptosis, inflammation, and fibrosis. This narrative review provides a concise overview of the emerging role of ceramides in cardiovascular disease with an emphasis on atherosclerotic vascular disease and heart failure, suggesting the potential use of ceramides in risk stratification and as putative therapeutic targets. Recent developments based on observational evidence and genetic associations, including Mendelian randomization studies in humans, are summarized and put into context with experimental evidence for the role of ceramides in human and animal models of disease. Emerging scores composed of ceramides and phosphatidylcholines that are based on the length and desaturation of the N-acyl chains are discussed in the light of novel data demonstrating age- and sex-specific differences. Also reviewed is the structural heterogeneity of the sphingoid bases, including non-conventional sphingolipids that are increasingly recognized for their importance in health and disease. Lastly, novel targets and potential modalities for tissue-specific transfer of drugs are discussed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeramidesCardiovascular DiseasesCardiovascular AgentsCardiovascular SystemHumansAnimalsRisk FactorsRisk AssessmentSignal TransductionHeart Disease Risk FactorsMolecular Targeted Therapy

Stichwörter der Autor:innen

Atherosclerotic vascular diseaseCeramidesHeart failureRisk stratificationTherapy

Substanzen

CeramidesCardiovascular Agents

Autor:innen und Institutionen

  • Department of Cardiology, Kerckhoff-Klinik, Campus of the University of Giessen, Benekestr. 2-8, D-61231 Bad Nauheim, Germany.
  • German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Benekestr. 2-8, D-61231 Bad Nauheim, Germany.
  • Vorarlberg Institute for Vascular Investigation & Treatment (VIVIT), Carinagasse 47, AT-6800 Feldkirch, Austria.
  • Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Hufelandstrasse 55, D-45122 Essen, Germany.
  • Department of Medicine and Research Center, Montreal Heart Institute and Université de Montréal, 5000, Bélanger Street, Montreal, Quebec, Canada.
  • Department of Integrative Physiology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA.

ORCID-Profile: Roland Klingenberg, Dobromir Dobrev, Winfried März, Arnold von Eckardstein

Förderung

  • NIH HHS
  • German Centre for Cardiovascular Research
  • European Union
  • Kerckhoff Research Foundation
  • NHLBI NIH HHS
  • Research Training Group 2989
  • Deutsche Forschungsgemeinschaft
  • MAESTRIA

Zitieren

APA

Klingenberg, R., Leiherer, A., Dobrev, D., Kaski, J. C., Levkau, B., März, W., Sossalla, S., von Eckardstein, A., & Drexel, H. (2025). Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets. Cardiovascular Research, 121(9), 1345-1358. https://doi.org/10.1093/cvr/cvaf093

Vancouver

Klingenberg R, Leiherer A, Dobrev D, Kaski JC, Levkau B, März W, et al. Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets. Cardiovascular Research. 2025;121(9):1345-1358. doi:10.1093/cvr/cvaf093

BibTeX
@article{Klingenberg2025,
  author = {Klingenberg, Roland and Leiherer, Andreas and Dobrev, Dobromir and Kaski, Juan C and Levkau, Bodo and März, Winfried and Sossalla, Samuel and von Eckardstein, Arnold and Drexel, Heinz},
  title = {Ceramides in cardiovascular disease: emerging role as independent risk predictors and novel therapeutic targets},
  journal = {Cardiovascular Research},
  year = {2025},
  volume = {121},
  number = {9},
  pages = {1345--1358},
  doi = {10.1093/cvr/cvaf093}
}
Kostenlos starten →